DK0587220T3 - Enterisk coatede, bløde kapsler og fremgangsmåde til fremstilling deraf - Google Patents

Enterisk coatede, bløde kapsler og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0587220T3
DK0587220T3 DK93202463.1T DK93202463T DK0587220T3 DK 0587220 T3 DK0587220 T3 DK 0587220T3 DK 93202463 T DK93202463 T DK 93202463T DK 0587220 T3 DK0587220 T3 DK 0587220T3
Authority
DK
Denmark
Prior art keywords
mixture
preparation
soft capsules
weight
triacetin
Prior art date
Application number
DK93202463.1T
Other languages
Danish (da)
English (en)
Inventor
Shrikant Narayan Pagay
Gregg Stetsko
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DK0587220T3 publication Critical patent/DK0587220T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DK93202463.1T 1992-08-26 1993-08-21 Enterisk coatede, bløde kapsler og fremgangsmåde til fremstilling deraf DK0587220T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/935,505 US5330759A (en) 1992-08-26 1992-08-26 Enteric coated soft capsules and method of preparation thereof

Publications (1)

Publication Number Publication Date
DK0587220T3 true DK0587220T3 (da) 1997-12-01

Family

ID=25467257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93202463.1T DK0587220T3 (da) 1992-08-26 1993-08-21 Enterisk coatede, bløde kapsler og fremgangsmåde til fremstilling deraf

Country Status (12)

Country Link
US (1) US5330759A (ja)
EP (1) EP0587220B1 (ja)
JP (1) JP3983823B2 (ja)
AT (1) ATE152618T1 (ja)
AU (1) AU672982B2 (ja)
CA (1) CA2101095C (ja)
DE (1) DE69310461T2 (ja)
DK (1) DK0587220T3 (ja)
ES (1) ES2104044T3 (ja)
GR (1) GR3024351T3 (ja)
HU (1) HUT64833A (ja)
MX (1) MX9305108A (ja)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US6224911B1 (en) * 1993-03-16 2001-05-01 Syntex (U.S.A.) Llc Process for the preparation of enteric coated pharmaceutical dosage forms
ATE414509T1 (de) * 1994-07-08 2008-12-15 Astrazeneca Ab Aus vielen einzeleinheiten zusammengesetzte tablettierte dosisform
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
JP3625940B2 (ja) * 1996-01-29 2005-03-02 信越化学工業株式会社 水系液のカプセルおよびその製造方法
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6440448B1 (en) 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US6139875A (en) * 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
US20070122481A1 (en) * 1998-11-02 2007-05-31 Elan Corporation Plc Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
JP4613275B2 (ja) * 1998-11-02 2011-01-12 エラン ファーマ インターナショナル，リミティド 多粒子改質放出組成物
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
GB9824658D0 (en) * 1998-11-11 1999-01-06 Brown Malcolm D A capsule based drug delivery system
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR20130010512A (ko) 1999-10-29 2013-01-28 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
KR100960200B1 (ko) 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
DK1545475T3 (da) 2002-10-01 2014-07-28 Banner Pharmacaps Inc Enterisk sammensætning til fremstillingen af blød kapselvæg
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
US20050152969A1 (en) * 2004-01-08 2005-07-14 Chiprich Timothy B. Colored liquid-filled soft capsules and method of manufacture thereof
WO2006063078A2 (en) * 2004-12-08 2006-06-15 Elan Corporation, Plc Topiramate pharmaceuticals composition
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
MX2007012763A (es) * 2005-04-12 2008-01-14 Elan Pharma Int Ltd Composiciones de liberacion controlada que comprenden una cefalosporina para el tratamiento de infeccion bacteriana.
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
US20070148248A1 (en) 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
EP2219621B1 (en) 2007-11-12 2013-12-25 Pharmaceutics International, Inc. Tri-molecular complexes and their use in drug delivery systems
WO2009136493A1 (ja) * 2008-05-08 2009-11-12 パナソニック株式会社 不揮発性記憶素子、及び、不揮発性記憶素子又は不揮発性記憶装置の製造方法
US8647645B2 (en) 2009-05-12 2014-02-11 Bpsi Holdings, Llc Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
JP5841526B2 (ja) * 2009-05-12 2016-01-13 ビーピーエスアイ ホールディングス， エルエルシー 微粒子径粘着性除去剤を含むフィルムコーティング、及びこれによってコーティングされた基材
US8663671B2 (en) 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
BR112014024159A2 (pt) 2012-03-29 2017-06-20 Therabiome Llc Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice.
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
SI2946774T1 (sl) * 2014-05-19 2020-07-31 Tillotts Pharma Ag Obložene kapsule s prirejenim sproščanjem
CA2950311C (en) 2014-06-23 2019-05-14 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
KR102294577B1 (ko) * 2015-01-12 2021-08-26 엔터리스 바이오파마, 인크. 고체 경구 제형
CN104825418B (zh) * 2015-05-07 2018-05-15 上海信谊万象药业股份有限公司 一种硝苯地平软胶丸及其制备方法
CA2997915A1 (en) 2015-09-15 2017-03-23 C.B. Fleet Company, Incorporated Bisacodyl compositions and delivery apparatus
JP7423608B2 (ja) 2018-09-05 2024-01-29 レナファルマ・アクチボラグ 鉄含有組成物およびその使用
WO2020225395A1 (en) 2019-05-07 2020-11-12 Bausch Health Ireland Limited Liquid oral dosage formulations of methylnaltrexone
EP4142727A1 (en) 2020-05-02 2023-03-08 Bausch Health Ireland Limited Methods of reducing mortality risk in subjects suffering from an underlying disease or condition by administration of methylnaltrexone
EP4169503A1 (en) 2021-10-20 2023-04-26 Tessenderlo Group NV Composition comprising gelatin, gelatin films and capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3234331C2 (de) * 1982-09-16 1986-06-05 A. Nattermann & Cie GmbH, 5000 Köln Verfahren und Lösungen zum Beschichten von Gelatinekapseln mit magensaftresistenten Überzügen
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
EP0313845A1 (en) * 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
US5047258A (en) * 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process
NL9002336A (nl) * 1990-10-24 1992-05-18 Leuven K U Res & Dev Bekledings- of matrixmateriaal voor geneesmiddelen.

Also Published As

Publication number Publication date
CA2101095C (en) 2004-01-20
MX9305108A (es) 1994-02-28
GR3024351T3 (en) 1997-11-28
AU672982B2 (en) 1996-10-24
HUT64833A (en) 1994-03-28
CA2101095A1 (en) 1994-02-27
DE69310461D1 (de) 1997-06-12
DE69310461T2 (de) 1997-12-11
ES2104044T3 (es) 1997-10-01
US5330759A (en) 1994-07-19
AU4488893A (en) 1994-03-03
EP0587220B1 (en) 1997-05-07
JP3983823B2 (ja) 2007-09-26
EP0587220A1 (en) 1994-03-16
ATE152618T1 (de) 1997-05-15
HU9302426D0 (en) 1993-11-29
JPH06157295A (ja) 1994-06-03

Similar Documents

Publication Publication Date Title
DK0587220T3 (da) Enterisk coatede, bløde kapsler og fremgangsmåde til fremstilling deraf
US5112621A (en) Sustained release pharmaceutical composition of diltiazem
US5834023A (en) Diltiazem controlled release formulation
ITRM970207A1 (it) Composizioni farmaceutiche con rivestimento enterico
PL323362A1 (en) Method of treating inflammatory inteestine diseases using oral preparations of polyunsaturated omega-3 acids
CA2170748C (en) Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
RU2004121786A (ru) Лекарственные составы длительного высвобождения, содержащие в качестве активного соединения венлафаксина гидрохлорид
RU2011101918A (ru) Получение лекарственных форм миорелаксантов скелетных мышц с контролируемым высвобождением
EA023971B1 (ru) Применение композиции, содержащей покрытые энтеросолюбильной оболочкой цистамин или цистеамин, для лечения цистиноза и способ лечения цистиноза
JPS57171428A (en) Preparation of coated solid preparation
DK150008C (da) Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
NO175618C (no) Fremgangsmåte for fremstilling av en farmasöytisk formulering med kontrollert frigjöring for oral administrering omfattende atskilte enheter omfattende acrivastin eller et salt derav
KR970001656B1 (ko) 조절흡수 딜티아젬 제제
FI821422A0 (fi) Foerfarande foer framstaellning av ett nytt farmaceutiskt preparat
US6221396B1 (en) Oral cisapride dosage forms with an extended duration
ATE25670T1 (de) 5-aminosalicylsaeure-o-sulfate von physiologisch unbedenklichen basen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IL151150A (en) A multiparticulate form of a drug containing at least two different forms of coated tablets
KR940001887A (ko) 신규 경구제형
KR20000053327A (ko) 결장내 운반에 사용되는 약학적 제형
EP1060743A1 (en) Oral cisapride dosage forms with an extended duration